Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3297512018 | Dolutegravir sodium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3297665018 | Dolutegravir sodium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dolutegravir sodium | Is a | Organic nitrogen compound | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Is a | Anti-infective agent (substance) | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Has disposition (attribute) | Disposition | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 3 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR